{
  "pmid": "22442352",
  "uid": "22442352",
  "title": "How the FDA forgot the evidence: the case of donepezil 23 mg.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Schwartz",
      "fore_name": "Lisa M",
      "initials": "LM",
      "name": "Lisa M Schwartz",
      "affiliations": [
        "VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, Vermont 05009, USA."
      ]
    },
    {
      "last_name": "Woloshin",
      "fore_name": "Steven",
      "initials": "S",
      "name": "Steven Woloshin",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "BMJ (Clinical research ed.)",
    "iso_abbreviation": "BMJ",
    "issn": "1756-1833",
    "issn_type": "Electronic",
    "volume": "344",
    "pub_year": "2012",
    "pub_month": "Mar",
    "pub_day": "22"
  },
  "start_page": "e1086",
  "pages": "e1086",
  "language": "eng",
  "publication_types": [
    "Journal Article"
  ],
  "keywords": [
    "Alzheimer Disease",
    "Donepezil",
    "Drug Approval",
    "Drug Labeling",
    "Evidence-Based Medicine",
    "Humans",
    "Indans",
    "Marketing",
    "Nootropic Agents",
    "Piperidines",
    "United States",
    "United States Food and Drug Administration"
  ],
  "article_ids": {
    "pubmed": "22442352",
    "doi": "10.1136/bmj.e1086",
    "pii": "bmj.e1086"
  },
  "doi": "10.1136/bmj.e1086",
  "dates": {
    "completed": "2012-05-03",
    "revised": "2018-12-01"
  },
  "chemicals": [
    "Indans",
    "Nootropic Agents",
    "Piperidines",
    "Donepezil"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:57:03.492778",
    "pmid": "22442352"
  }
}